Squamous cell carcinoma, adenoid|0 0 0 0 0 0 0 1 0 2 4 5 11 17 10 18 8 10 27 0
Malignant teratoma, intermediate|0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Pineocytoma|0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 3 0 0
Leydig cell tumor, malignant|0 0 0 0 0 2 2 1 1 2 1 4 4 2 3 1 6 0 0 0
Carcinoma in pleomorphic adenoma|0 0 0 0 0 0 2 4 3 9 9 14 13 18 21 27 28 28 18 29
Embryonal carcinoma, NOS|16 1 8 119 373 403 318 155 94 56 38 28 24 13 9 4 6 7 0 0
Plasmacytoma, extramedullary|0 0 0 0 2 3 9 12 18 28 46 74 114 129 141 124 168 115 81 29
Follicular lymphoma, grade 1|0 0 2 3 10 53 108 164 260 387 559 826 1040 1220 1288 1110 1090 933 549 268
Astroblastoma|6 8 5 6 8 8 5 6 4 7 12 10 13 13 11 10 6 0 0 0
Epithelioid cell melanoma|0 0 0 1 3 4 7 5 10 15 19 39 36 60 57 56 38 57 63 29
Papillary carcinoma, follicular variant|0 8 27 104 281 449 497 555 566 608 686 723 675 650 531 428 278 187 99 29
Hemangioma, NOS|0 0 0 0 2 2 0 1 2 4 4 8 2 2 0 4 2 3 0 0
Ependymoma, NOS|116 34 37 26 38 55 48 47 49 55 57 74 70 62 46 36 16 10 9 0
Epithelioid hemangioendothelioma, malignant|0 0 0 2 3 1 4 5 4 3 7 7 8 7 4 10 8 3 0 0
Mucinous adenocarcinofibroma|0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 2 0 0 0
Dermoid cyst, NOS|0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0
Hemangiosarcoma|2 0 0 4 15 20 24 22 26 36 47 95 114 166 185 236 269 378 351 238
Paget disease and intraductal ca.|0 0 0 0 0 1 12 24 34 54 65 104 157 184 186 228 219 244 135 208
Hepatocellular carcinoma, NOS|5 9 15 15 33 50 82 137 294 717 1295 1896 2537 3123 3470 3592 3105 2478 1675 774
Serous surface papillary carcinoma|0 0 0 0 4 10 14 30 48 94 154 259 387 464 412 468 385 295 162 59
Inflammatory carcinoma|0 0 0 0 2 16 58 91 133 209 243 321 347 317 315 289 276 320 387 208
Neuroendocrine carcinoma|0 0 0 7 21 22 39 55 93 171 263 419 591 839 938 988 1012 680 504 297
Sq. cell carc. in situ with question. stromal invas.|0 0 0 0 3 4 5 3 2 4 1 4 8 4 4 5 6 3 9 0
Chordoid glioma|0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0 0
Teratoma with malig. transformation|0 0 0 0 0 1 0 1 1 0 2 2 3 3 3 0 2 0 0 0
Sq. cell carcinoma, micro-invasive|0 0 0 8 70 257 305 247 219 181 153 162 198 225 185 128 133 72 36 89
Leiomyoma, NOS|0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Adenocarcinoma in situ in familial polyp. coli|0 0 0 0 0 1 1 0 0 0 1 0 3 3 3 5 6 0 0 0
Yolk sac tumor|88 7 12 29 45 47 30 15 11 6 6 3 2 6 3 1 0 0 9 0
Adenocarcinoma in adenoma. polyposis coli|0 0 0 1 3 6 7 8 6 8 13 8 12 25 18 16 4 3 0 0
Pineoblastoma|8 6 4 5 5 3 2 2 0 1 2 2 2 2 0 1 4 0 0 0
Trichilemmocarcinoma|0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 29
Refractory anemia|0 0 0 1 1 1 2 1 5 7 17 44 54 111 133 264 442 446 468 178
Papillary carcinoma in situ|0 0 0 0 3 3 4 4 9 18 20 44 59 97 112 125 111 169 81 89
Leiomyosarcoma, NOS|2 3 7 17 30 75 117 181 276 415 524 665 820 926 940 981 986 933 927 595
Spindle cell melanoma, NOS|0 2 2 5 11 17 16 23 26 46 55 91 136 158 161 195 237 244 387 297
Cavernous hemangioma|1 0 1 0 3 1 3 3 1 2 5 3 1 3 2 4 0 0 0 0
Ependymoma, anaplastic|24 8 6 2 2 6 1 3 5 3 4 4 2 3 1 0 0 3 0 0
Papillary carcinoma, NOS|0 6 44 191 543 799 1009 961 959 999 1085 1278 1597 1830 1763 1730 1729 1650 1539 1072
Papillary microcarcinoma|0 0 0 0 4 14 22 30 39 50 53 70 71 56 34 33 12 7 36 0
Serous papillary cystic tumor of borderline malignancy (C56.9)|0 0 1 10 37 56 81 85 86 92 85 89 79 93 113 102 56 39 18 0
ML, small B lymphocytic, NOS|3 4 3 6 14 26 43 64 127 223 381 712 1059 1477 1728 1942 2204 1916 1494 1191
Hepatocellular carcinoma, fibrolamellar|0 0 0 6 10 6 3 4 1 2 4 2 4 6 5 5 4 3 0 0
Merkel cell carcinoma|0 0 0 0 0 1 1 2 10 19 46 62 118 202 303 445 667 886 981 923
Clear cell chondrosarcoma|0 0 0 0 1 0 0 0 0 1 0 0 0 0 0 2 0 0 0 0
Squamous intraepithelial neoplasia, grade III|0 0 6 567 2193 2566 2009 1339 1056 852 663 617 540 530 441 329 296 248 189 89
Mixed germ cell tumor|5 4 21 120 267 286 247 145 89 48 35 17 9 8 5 2 4 0 0 29
Sclerosing sweat duct carcinoma|0 0 0 0 0 1 0 1 1 2 6 12 14 17 13 18 24 32 54 0
Adenocarc. in situ in mult. adenomatous polyps|0 0 0 0 0 0 1 0 0 0 1 2 10 4 11 6 10 7 9 29
Craniopharyngioma|4 4 0 2 1 2 2 0 3 3 6 3 4 3 0 5 8 3 0 0
Adenocarcinoma in mult. adenomatous polyps|0 0 0 0 1 1 1 0 1 5 9 5 17 28 19 32 28 18 0 29
Spindle cell melanoma, type A|0 0 0 1 0 0 0 0 1 1 1 4 6 6 3 6 2 10 0 0
Verrucous carcinoma, NOS|0 0 0 0 1 5 12 14 22 37 66 118 194 220 265 263 456 417 432 387
Endometrial stromal sarcoma|0 0 0 1 2 8 19 28 46 72 65 71 73 83 88 83 73 75 63 29
Epithelioid leiomyosarcoma|0 0 0 2 2 4 4 8 11 24 26 41 55 58 74 51 64 64 18 0
Papillary ependymoma|1 0 0 0 0 0 0 0 0 0 1 0 0 1 0 0 0 0 0 0
Papillary carcinoma, oxyphilic cell|0 0 0 0 0 0 0 0 0 1 0 0 0 0 1 0 0 0 0 0
Venous hemangioma|0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2 0 0 0
ML, large B-cell, diffuse, immunoblastic, NOS|2 5 5 18 37 63 123 142 148 150 159 248 372 498 579 644 673 666 360 506
Neurofibroma, NOS|0 0 0 0 2 1 0 2 0 1 1 0 2 1 1 1 0 0 0 0
Neurofibromatosis, NOS|3 4 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Glioma, malignant|150 153 96 47 45 56 63 66 62 74 107 149 205 281 309 349 485 486 270 119
ML, lymphoplasmacytic|0 0 0 1 2 4 7 11 22 31 58 93 135 181 204 260 322 288 252 178
Hepatocellular carcinoma, scirrhous|0 0 0 0 0 0 0 0 0 1 1 0 0 1 1 1 2 0 0 0
Oxyphilic adenocarcinoma|0 0 1 3 8 26 25 51 50 70 95 101 137 175 163 189 180 205 90 89
Malignant peripheral nerve sheath tumor|2 4 12 19 28 27 23 23 31 21 34 36 50 39 53 59 52 79 27 59
Papillary cystadenocarcinoma, NOS|0 0 0 1 9 9 16 19 29 57 93 136 159 147 162 141 121 129 45 119
Dedifferentiated chondrosarcoma|0 0 0 0 0 0 0 0 0 2 3 3 0 4 4 6 18 0 0 0
Squamous cell carcinoma with horn formation|0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Chondroblastoma, malignant|0 0 2 1 1 1 0 0 0 0 0 0 0 0 1 0 0 0 0 0
Eccrine papillary adenocarcinoma|0 0 0 0 0 0 0 1 0 1 1 0 0 0 1 1 0 0 0 0
Fibrosarcoma, NOS|9 6 13 22 30 34 35 34 31 39 56 67 110 105 115 143 158 158 72 29
Myxopapillary ependymoma|0 1 1 2 2 7 5 3 4 7 6 8 0 1 6 2 0 0 0 0
Adamantinomatous craniopharyngioma|2 2 1 0 0 0 0 0 1 3 1 2 0 0 0 1 0 3 0 0
Peripheral neuroectodermal tumor|3 5 6 12 5 7 6 6 4 3 4 5 5 7 3 8 2 14 0 0
Sertoli cell carcinoma|0 0 0 1 1 0 0 0 1 1 1 0 1 0 2 1 0 3 0 0
Refractory anemia with sideroblasts|0 0 0 0 0 1 1 3 3 4 12 29 39 73 113 216 381 320 360 119
Follicular lymphoma, grade 3|0 1 1 3 5 20 33 48 84 128 177 302 385 486 513 506 564 554 297 148
Papillary squamous cell carcinoma, non-invasive|0 0 0 0 0 0 1 0 1 3 8 8 13 12 15 14 18 7 0 0
Endometrial stromal sarcoma, low grade|0 0 0 0 0 1 5 8 15 31 22 9 7 5 6 5 8 10 0 0
Dysgerminoma|0 7 23 71 73 96 67 37 23 30 29 16 19 10 7 14 6 3 0 0
Spindle cell melanoma, type B|0 0 0 1 3 3 12 6 11 21 34 43 52 54 73 40 54 28 45 0
Papillary squamous cell carcinoma|0 0 0 0 2 3 8 6 14 29 41 56 99 129 100 112 133 118 189 178
Papillary carcinoma, encapsulated|0 0 0 0 1 4 3 8 6 8 7 5 6 7 2 2 0 0 0 0
Fibrillary astrocytoma|21 17 16 11 22 28 40 25 26 24 31 33 53 67 54 31 16 18 0 0
Mal. melanoma in giant pigmented nevus|2 0 1 0 4 2 6 8 11 11 13 17 10 13 11 9 4 7 0 0
Melanotic neurofibroma|0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Gliomatosis cerebri|0 0 0 0 0 1 0 0 0 1 1 1 1 7 7 5 10 0 0 0
Hepatocellular carcinoma, spindle cell variant|0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 2 0 0 0 0
Follicular adenocarcinoma, NOS|0 1 12 37 93 144 178 172 180 199 204 242 304 327 327 303 271 273 189 119
Papillary cystadenoma, borderline malignancy (C56.9)|0 0 0 1 2 3 3 3 5 3 5 6 1 7 2 1 0 0 0 0
Mesonephroma, malignant|0 0 0 0 2 2 1 0 3 10 16 14 16 9 12 13 6 3 0 0
Atypical carcinoid tumor|0 0 0 0 0 0 1 0 2 5 6 5 7 18 14 10 14 14 0 0
Cholangiocarcinoma|0 0 0 0 2 8 10 34 56 96 165 304 421 629 782 1010 1366 1484 1566 1370
Prolymphocytic leukemia, NOS|0 0 0 1 1 0 0 0 2 3 6 14 32 46 46 78 69 82 153 29
Lobular carcinoma in situ|0 0 0 0 1 10 48 184 628 1227 1250 1039 974 874 620 464 379 270 99 119
Lobular carcinoma, NOS|0 0 0 0 3 29 101 306 840 1665 2131 2851 3880 4805 5115 5403 5732 5454 4836 3097
Fibromyxosarcoma|1 0 3 2 4 7 8 7 12 15 14 15 16 33 24 32 26 28 27 59
Myxoid chondrosarcoma|0 0 1 1 1 5 7 6 8 10 12 8 16 23 15 16 6 32 0 0
Eccrine poroma, malignant|0 0 0 0 0 0 0 0 0 1 3 1 2 7 4 9 26 14 36 29
Papillary craniopharyngioma|0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 1 0 0 0 0
Askin tumor|0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Parosteal osteosarcoma|0 0 7 8 13 7 7 5 1 1 2 1 3 1 1 0 0 3 0 0
Adenocarcinoma in situ in adenomatous polyp|0 0 0 1 3 6 15 30 69 134 369 595 1089 1454 1545 1661 1493 1296 828 327
Marginal zone B-cell lymphoma, NOS|0 0 1 3 9 19 27 46 66 139 189 295 366 501 667 730 848 925 522 327
Refractory anemia with excess blasts|0 1 0 1 0 0 1 3 6 13 21 38 72 96 157 248 373 378 243 119
Adenocarcinoma in adenomatous polyp|0 0 0 1 7 15 35 75 165 355 866 1524 2603 3698 4094 4328 4597 4063 3124 1757
Seminoma, NOS|0 0 1 40 347 840 1071 923 712 470 301 205 139 102 59 49 26 32 27 0
Papillary carcinoma, columnar cell|0 0 0 0 0 1 3 4 4 5 5 4 12 9 12 10 8 10 27 29
Pilocytic astrocytoma|171 154 141 96 61 49 26 21 21 17 17 14 17 12 12 8 6 7 0 0
Mixed glioma|17 12 11 19 30 47 66 49 62 51 50 52 49 56 27 28 4 18 0 0
Hepatocellular carcinoma, clear cell type|0 0 0 0 0 0 0 0 0 2 4 5 4 8 4 9 18 10 18 0
Follicular adenocarcinoma well diff.|0 0 0 4 18 28 30 23 18 26 24 29 25 36 31 27 28 14 18 29
Mantle cell lymphoma|0 0 0 0 3 3 12 15 40 77 154 243 338 479 516 599 596 515 432 327
Ganglioneuroma|0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Kupffer cell sarcoma|0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0
Bile duct cystadenocarcinoma|0 0 0 0 0 0 0 0 0 0 0 0 0 0 2 5 2 0 0 0
Solid pseudopapillary carcinoma|0 0 0 0 0 0 0 0 1 3 0 2 1 0 0 1 0 0 0 0
Prolymphocytic leukemia, B-cell type|0 0 0 0 0 0 0 0 0 0 0 2 4 3 4 5 10 14 9 29
Malignant cystic nephroma|0 0 0 0 0 0 0 0 1 0 0 1 0 1 1 2 0 0 0 0
Ganglioneuroblastoma|113 22 6 4 3 1 1 0 0 0 0 1 2 3 1 4 0 0 0 0
Lymphoid leukemia, NOS|7 6 3 5 2 2 3 7 8 24 32 58 72 119 146 179 274 342 414 536
Infiltrating ductular carcinoma|0 0 0 0 0 0 8 18 23 38 54 83 108 139 108 99 89 126 90 89
Periosteal fibrosarcoma|0 0 0 0 1 1 0 0 0 0 0 2 1 5 3 0 0 0 0 0
Periosteal osteosarcoma|0 0 0 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Refract. anemia with excess blasts in transformation|0 0 0 0 0 0 0 0 1 0 1 4 8 6 15 24 36 28 0 0
Osteosarcoma, NOS|8 59 178 192 76 44 38 26 23 31 34 51 79 91 78 116 75 90 72 89
Adenosarcoma|0 0 0 0 3 4 6 10 15 20 25 32 40 59 42 51 30 36 45 0
Angiomyosarcoma|0 0 0 0 0 1 0 0 0 0 1 0 3 2 2 2 4 3 0 0
Subependymoma|0 0 0 0 0 1 1 1 2 4 1 5 2 1 1 1 2 3 0 0
Seminoma, anaplastic|0 0 0 4 18 54 60 49 37 27 18 14 21 14 7 10 8 3 0 0
Tubular adenocarcinoma|0 0 0 0 0 2 13 49 159 351 485 573 764 899 903 888 846 562 423 148
Ovarian stromal tumor, mal.|0 0 0 1 2 1 0 1 1 2 0 1 6 0 4 5 0 3 0 0
Medullary carcinoma with amyloid stroma|0 5 11 10 15 26 34 32 39 38 54 67 78 84 86 72 66 28 27 0
Burkitt lymphoma, NOS|44 77 70 49 38 49 64 64 66 57 54 65 50 68 82 86 93 104 36 89
Small cell carcinoma, NOS|2 0 1 6 16 28 43 124 364 906 2126 4622 7602 10105 10377 9588 7534 4542 2278 744
Acidophil adenoma|0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0
Alveolar rhabdomyosarcoma|32 27 29 33 16 6 5 4 3 2 1 5 6 3 1 6 4 3 9 0
Follicular adenocarcinoma trabecular|0 0 0 1 3 4 4 3 7 6 11 11 11 9 12 6 0 7 18 0
Hepatocellular carcinoma, pleomorphic type|0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Meningioma, NOS|1 1 1 2 7 20 36 60 92 148 202 304 359 404 520 629 945 1300 1242 1459
Mycosis fungoides|1 3 4 10 22 41 56 79 100 150 187 284 365 436 449 386 454 353 234 238
Hodgkin granuloma [obs]|0 0 0 0 2 0 2 0 0 1 0 4 0 2 4 4 6 0 0 0
Klatskin tumor|0 0 0 0 0 1 0 1 0 9 15 19 25 46 72 101 135 198 198 119
Intraductal papillary-mucinous carcinoma, non-inv.|0 0 0 0 0 0 0 0 0 0 2 3 4 5 5 14 8 3 0 0
Meningiomatosis, NOS|0 0 0 0 0 0 0 0 0 1 1 2 1 6 5 8 4 21 9 0
Acidophil carcinoma|0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0 0 0
Intraductal papillary-mucinous carcinoma, invasive|0 0 0 0 0 0 0 0 0 1 0 2 5 10 7 5 6 0 0 0
Prolymphocytic leukemia, T-cell type|0 0 0 0 0 0 0 0 0 2 2 3 3 6 11 5 8 21 9 0
Intraductal and lobular in situ carcinoma|0 0 0 0 0 2 12 36 136 262 305 284 276 273 270 210 166 111 81 59
Meningioma, malignant|2 1 1 3 2 5 12 15 21 27 42 71 90 104 152 143 127 100 162 119
Infiltrating duct and lobular carcinoma|0 0 0 0 2 23 129 316 727 1338 1637 2038 2484 2772 2844 2909 2912 2348 1711 1250
Cystadenocarcinoma, NOS|0 0 0 2 3 3 13 14 31 39 65 103 127 138 124 148 186 216 306 178
Fascial fibrosarcoma|0 0 0 0 0 1 1 1 0 1 2 3 5 3 3 2 2 7 18 0
High grade surface osteosarcoma|0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0
Spermatocytic seminoma|0 0 0 0 2 4 4 4 4 8 6 5 11 13 6 14 16 7 9 29
Refractory cytopenia with multilineage dysplasia|0 0 0 0 0 0 0 1 2 3 5 14 32 38 60 93 144 126 81 29
Sarcoma, NOS|15 9 24 28 42 51 45 60 69 86 132 201 273 334 353 443 604 684 693 774
Chondrosarcoma, NOS|1 0 12 31 39 59 72 58 71 93 102 124 178 162 180 160 140 158 117 119
Myosarcoma|1 0 0 0 1 1 0 0 1 2 2 2 3 3 4 5 2 10 9 0
Supependymal giant cell astrocytoma|1 2 2 0 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Chondroblastic osteosarcoma|1 3 19 27 17 8 7 5 4 4 4 4 6 4 5 4 6 3 18 0
Carcinofibroma|0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 1 0 0 0 0
Precursor cell lymphoblastic lymphoma, NOS|34 41 44 43 41 38 39 22 17 20 15 29 40 45 51 48 66 46 36 0
Androblastoma, malignant|0 0 1 0 1 0 0 0 0 1 0 1 0 0 1 0 2 0 0 0
Mixed medullary-follicular carcinoma|0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 1 0 0 0 0
Mesothelioma, malignant|0 0 0 2 4 8 16 21 40 80 154 306 519 775 991 1149 1264 976 720 238
Oat cell carcinoma|0 0 0 0 0 4 11 37 150 370 871 1852 3004 3759 3323 2474 1729 875 432 89
Rhabdomyosarcoma with ganglionic differentiation|1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Polar spongioblastoma|0 0 0 1 0 1 0 0 0 0 1 0 0 0 0 1 0 0 9 0
Anaplastic large cell lymphoma, T-cell and Null cell type|4 8 18 22 12 18 28 26 34 29 36 57 63 77 100 87 109 122 135 29
ML, mixed sm. and lg. cell, diffuse|0 3 4 9 19 28 35 51 80 96 161 282 469 572 726 772 811 814 729 297
Fetal adenocarcinoma|0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0
Meningothelial meningioma|0 0 0 0 0 2 6 7 13 23 25 26 36 42 34 29 34 36 9 0
Gangliocytoma|0 0 0 0 1 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0
Protoplasmic astrocytoma|4 0 0 2 4 6 7 2 3 2 2 5 6 1 2 2 2 0 0 0
Hodgkin sarcoma [obs]|0 0 0 0 0 0 0 0 0 2 0 1 1 1 5 6 2 3 0 0
Granular cell carcinoma|0 0 0 0 1 1 7 8 17 30 43 81 127 128 155 179 164 90 54 0
Sezary syndrome|0 0 0 0 0 0 0 1 1 2 3 9 11 14 16 20 38 28 9 29
Precursor cell lymphoblastic leukemia, NOS|1537 725 423 329 199 149 135 103 93 106 136 172 236 255 274 302 422 446 378 625
Islet cell carcinoma|0 0 0 2 5 7 14 15 27 43 56 77 105 121 113 102 40 54 27 29
Mesenchymoma, malignant|6 4 3 1 3 2 2 2 4 4 5 11 13 18 21 20 22 7 9 0
Infiltr. duct mixed with other types of carcinoma, in situ|0 0 0 0 0 7 15 57 242 390 450 625 603 618 591 618 558 410 243 59
Serous cystadenocarcinoma, NOS|0 0 0 2 8 21 30 46 102 208 299 467 698 763 725 678 665 389 324 89
Choriocarcinoma|0 0 3 46 82 98 67 40 24 28 12 9 8 10 5 2 6 0 9 0
Infiltr. duct mixed with other types of carcinoma|0 0 0 0 0 6 14 37 86 169 181 258 340 324 354 437 464 432 468 327
Infantile fibrosarcoma|26 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2 0 0 0
Intratubular malignant germ cells|0 0 1 0 1 3 1 1 0 0 0 0 0 0 0 1 0 0 0 0
Medullary carcinoma, NOS|0 0 5 2 17 98 226 308 390 502 541 626 688 684 579 482 460 450 342 148
Juxtacortical chondrosarcoma|0 0 1 0 0 0 0 0 0 0 0 1 0 0 2 1 2 0 0 0
Germinoma|2 12 42 58 60 44 34 30 22 20 10 11 8 7 3 5 2 0 0 0
Myelodysplastic syndr. with 5q deletion syndrome|0 0 0 0 0 0 0 0 0 0 2 2 8 11 16 32 50 54 27 89
Spindle cell sarcoma|2 4 3 8 14 12 17 18 28 25 55 82 89 98 120 168 172 190 153 148
Fibroblastic osteosarcoma|0 1 7 9 8 5 2 2 2 6 2 5 3 4 4 2 0 3 0 0
Stromal sarcoma, NOS|0 0 0 0 1 1 1 5 8 13 13 15 18 19 19 25 14 25 36 29
Myxoid leiomyosarcoma|0 0 0 0 0 1 1 2 4 6 9 6 6 13 10 8 2 10 9 0
Sertoli-Leydig cell tumor, poorly differentiated|0 0 0 5 3 1 0 0 0 0 1 2 0 1 3 4 6 0 0 0
Mixed medullary-papillary carcinoma|0 0 0 0 0 0 0 0 1 3 0 0 5 2 0 0 0 3 0 0
Precursor B-cell lymphoblastic lymphoma|5 4 5 2 2 0 1 0 0 0 0 3 2 0 1 0 0 7 0 0
Splenic marginal zone B-cell lymphoma|0 0 0 0 0 0 0 1 1 6 10 18 23 28 29 49 54 39 36 0
Acute monocytic leukemia|43 9 13 21 20 24 20 24 33 48 66 93 148 203 212 295 336 356 297 208
Small cell carcinoma, fusiform cell|0 0 0 0 0 0 0 0 0 2 4 9 11 20 15 5 10 7 0 0
Pleomorphic xanthoastrocytoma|1 2 9 9 6 3 4 1 1 2 2 2 1 3 1 0 0 0 0 0
Fibrous mesothelioma, malignant|0 0 0 0 0 0 1 3 4 6 14 19 52 88 97 126 129 79 72 0
Adenoid cystic carcinoma|0 0 2 7 23 38 62 87 110 156 215 275 341 378 420 336 357 407 261 268
Chronic myeloproliferative disease, NOS|1 0 0 0 1 1 2 6 6 18 23 30 54 83 109 174 235 216 189 148
Dysplastic gangliocytoma of cerebellum (Lhermitte-Duclos)|0 0 0 0 0 0 0 0 0 1 0 0 0 1 0 0 0 0 0 0
Giant cell and spindle cell carcinoma|0 0 0 0 0 0 0 3 2 9 16 20 28 31 42 32 36 50 27 29
Gemistocytic astrocytoma|2 0 0 0 4 10 24 24 23 23 23 25 37 46 40 29 16 10 0 0
Fibrous meningioma|0 0 0 0 0 0 4 2 5 8 13 17 13 19 10 13 10 7 0 0
Mature T-cell lymphoma, NOS|4 5 7 6 11 14 19 27 32 43 55 91 136 150 180 179 267 219 153 148
Hodgkin lymphoma, nodular sclerosis, NOS|6 46 243 721 1135 1083 788 490 348 271 249 282 276 337 278 280 249 208 198 178
Ameloblastic odontosarcoma|0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0
Precursor B-cell lymphoblastic leukemia|183 72 43 34 20 16 15 13 13 17 20 28 25 30 28 25 10 32 0 0
Solitary fibrous tumor|0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0
Serous cystadenoma, borderline malignancy (C56.9)|0 0 0 9 20 38 39 50 58 57 57 61 62 78 71 58 42 39 54 0
Hodgkin lymphoma, NOS|2 9 28 86 163 163 132 109 94 94 111 142 191 225 252 271 292 288 207 119
Insulinoma, malignant|0 0 0 0 1 0 0 0 2 0 2 2 0 3 7 6 6 0 9 0
Embryonal sarcoma|3 3 2 2 1 0 1 0 0 0 0 0 0 1 0 0 0 3 0 0
B-cell chr. lymph. leuk./small lymphocytic lymphoma|1 0 0 0 2 7 36 79 206 476 1047 2066 3435 4746 5690 6464 7804 8642 9122 8697
Choriocarcinoma combined w/ other germ cell elements|0 0 2 29 77 77 49 20 13 9 4 3 0 2 0 0 0 0 0 0
Infiltrating lobular mixed with other types of carc.|0 0 0 0 0 0 0 1 13 24 38 46 80 85 59 83 56 64 108 59
Solitary fibrous tumor, malignant|0 0 0 0 0 1 0 1 0 3 2 5 12 4 7 4 8 3 0 0
Cerebellar sarcoma, NOS|0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0 0
Germ cell tumor, nonseminomatous|0 0 0 6 12 12 8 7 2 2 0 0 0 0 0 0 0 0 0 0
Therapy-related myelodysplastic syndrome, NOS|1 0 0 0 0 1 0 2 1 2 2 8 9 6 14 27 20 18 27 0
Giant cell sarcoma|0 0 1 1 2 3 2 6 7 12 14 31 33 49 46 56 64 100 99 89
Skin appendage carcinoma|0 0 1 1 3 3 6 8 9 20 23 34 40 56 75 78 103 82 72 29
Gastrointestinal stromal sarcoma|0 0 0 1 4 9 13 18 33 62 83 126 137 150 180 222 255 194 180 89
Telangiectatic osteosarcoma|1 2 6 4 3 1 1 0 0 0 1 0 0 2 1 0 6 0 0 0
Epithel. mesothelioma, mal.|0 0 0 0 1 2 2 4 9 28 47 113 160 198 236 302 284 198 63 89
Precursor T-cell lymphoblastic lymphoma|5 6 6 6 5 5 4 1 4 7 1 2 4 1 5 2 0 3 0 29
Cribriform carcinoma in situ|0 0 0 0 0 1 4 33 122 202 287 325 351 340 364 363 310 219 117 119
Gynandroblastoma, malignant|0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2 0 0 0
Desmoplastic infantile astrocytoma|1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Cribriform carcinoma|0 0 0 0 1 1 5 9 18 37 42 55 82 115 144 202 178 133 126 178
Small cell carcinoma, intermediate cell|0 0 0 0 0 0 1 4 8 27 72 138 244 359 312 321 251 122 27 29
Lymphangiosarcoma|0 0 0 0 0 0 0 0 0 1 1 2 1 2 9 6 14 7 9 0
Myelosclerosis with myeloid metaplasia|0 0 0 0 0 1 1 3 4 7 17 25 36 62 65 108 140 100 45 29
Hepatosplenic gamma-delta cell lymphoma|0 0 0 0 2 0 1 1 0 0 0 0 1 2 0 1 0 0 0 0
Thymoma, malignant, NOS|0 1 1 2 11 16 19 24 32 52 54 91 98 119 94 91 69 54 9 0
Follicular carcinoma, minimally invasive|0 0 0 3 7 7 12 12 17 22 19 17 13 13 18 12 6 14 0 0
Ameloblastic fibrosarcoma|0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0 0 0
Psammomatous meningioma|0 0 0 0 0 0 1 2 1 7 5 16 15 14 18 24 22 10 9 0
Giant cell carcinoma|0 0 0 0 0 0 1 6 12 41 56 93 144 188 186 172 148 72 81 29
Chromophobe adenoma|0 0 0 0 0 0 0 1 0 1 1 2 2 2 1 1 0 0 0 0
Embryonal rhabdomyosarcoma|132 82 41 53 21 10 9 5 6 3 2 9 7 9 6 2 8 3 0 29
Hodgkin lymphoma, nod. scler., cellular phase|0 6 9 24 44 33 26 18 17 17 12 20 31 31 14 14 20 21 18 0
Water-clear cell adenocarcinoma|0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0
Mal. melanoma in junctional nevus|0 0 1 2 15 15 9 12 15 15 29 27 30 24 22 24 28 25 9 0
Precursor T-cell lymphoblastic leukemia|8 8 14 10 3 4 2 1 3 4 3 0 0 3 2 2 2 3 0 0
Hodgkin lymphoma, lymphocyte-rich|1 9 21 31 40 44 36 33 30 32 31 40 43 60 42 41 34 28 18 29
Glucagonoma, malignant|0 0 0 0 0 1 0 1 1 1 2 1 2 7 6 1 2 3 0 0
Polymorphous low grade adenocarcinoma|0 0 0 0 0 1 0 1 3 7 6 11 7 12 9 10 10 28 9 0
Chromophobe carcinoma|0 0 0 0 0 1 0 0 0 5 5 3 1 1 13 8 6 0 0 0
Malignant teratoma, trophoblastic|0 0 0 0 0 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Olfactory neurogenic tumor|0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Medullary carcinoma with lymphoid stroma|0 0 0 0 1 5 8 19 18 21 24 24 28 26 21 20 14 10 9 29
Mucoepidermoid carcinoma|1 7 26 38 63 89 96 106 111 162 207 277 357 406 393 367 385 378 342 268
Small cell sarcoma|0 0 4 7 4 3 4 1 2 2 2 5 2 1 7 4 6 0 0 0
Osteosarcoma in Paget disease|0 0 0 0 0 0 0 0 0 0 2 0 6 6 13 17 10 3 9 0
Adenocarcinoma of anal glands|0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 1 0 0 0 0
Dysembryoplastic neuroepithelial tumor|1 2 1 2 1 1 1 0 1 1 0 0 0 0 0 0 0 0 0 0
Mesothelioma, biphasic, malignant|0 0 0 0 0 0 0 0 2 3 5 21 26 42 57 60 73 36 18 0
Combined small cell carcinoma|0 0 0 0 1 0 0 1 0 10 19 46 77 123 129 116 101 54 9 0
Granulosa cell tumor, malignant|0 0 1 4 4 12 18 21 33 48 68 70 71 79 55 58 48 39 27 0
Thymoma, type A, malignant|0 0 0 0 0 0 0 0 0 1 2 1 4 8 2 8 6 7 9 0
Essential thrombocythemia|0 0 0 1 7 10 11 18 24 40 47 68 100 136 168 262 292 399 261 59
Intestinal T-cell lymphoma|0 0 0 0 0 0 0 0 0 1 0 2 2 3 2 2 2 7 0 0
Primary effusion lymphoma|0 0 0 0 0 0 0 0 1 1 1 0 2 1 1 0 0 0 0 0
Angiomatous meningioma|0 0 0 0 0 0 0 0 1 1 4 6 3 6 3 1 4 0 9 0
Spindle cell carcinoma|0 0 0 0 0 1 3 7 13 16 26 62 93 123 145 162 172 126 162 29
Prolactinoma|0 0 2 3 2 4 2 7 4 2 1 0 0 6 0 0 2 0 0 0
Synovial sarcoma, NOS|1 5 20 24 36 34 24 24 19 16 21 21 21 19 16 24 16 10 0 0
Mixed cell adenocarcinoma|0 0 0 0 2 1 7 11 22 45 85 135 176 175 169 163 192 100 117 59
Hodgkin lymphoma, nod. scler., grade 1|2 3 8 17 28 23 30 20 14 10 12 11 18 14 16 18 24 18 18 0
Precancerous melanosis, NOS|0 0 0 0 3 2 4 3 4 2 5 6 9 17 4 10 4 10 18 0
Astrocytoma, NOS|155 157 160 144 192 242 263 236 236 255 347 503 640 839 717 665 497 299 288 119
Adenoma, NOS|0 0 0 1 4 6 7 5 10 15 14 19 12 30 16 17 36 28 18 29
Mal. melanoma in precan. melanosis|0 0 0 0 0 2 1 0 0 1 0 2 1 1 1 5 6 3 0 0
Clear cell adenocarcinoma, NOS|1 2 2 14 33 64 133 240 529 902 1395 2298 2869 3247 3183 2882 2500 1862 1035 506
Hodgkin lymphoma, mixed cellularity, NOS|5 29 40 116 214 225 172 147 130 140 183 208 277 309 339 343 353 266 198 178
Gastrinoma, malignant|0 0 0 0 2 0 3 5 4 6 7 11 9 12 11 8 2 0 0 0
Adenocarcinoma in situ|0 0 0 4 39 114 172 163 188 281 449 564 678 714 728 749 738 738 558 148
Carcinosarcoma, NOS|0 0 0 0 0 4 5 7 20 39 88 189 284 405 433 395 539 504 369 268
Olfactory neurcytoma|0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 2 0 0 0
Adenocarcinoma, NOS|1 2 6 49 225 737 1774 3352 6916 15586 34893 74402 129002 184465 209883 216591 216084 193199 151998 103917
Atypical medullary carcinoma|0 0 0 0 0 0 4 4 4 8 6 21 11 8 5 10 6 10 9 0
Small cell osteosarcoma|0 0 0 1 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0 0
Intraductal carcinoma, noninfiltrating, NOS|0 0 0 1 10 51 175 582 1469 2392 2864 3433 4041 4521 4400 4054 3436 2424 1161 625
Myelodysplastic syndrome, NOS|6 2 2 1 2 5 3 9 14 35 50 95 156 259 453 830 1276 1538 1594 1310
Epithelioid sarcoma|0 2 7 11 18 9 9 10 9 11 13 14 11 14 15 22 14 14 27 29
Immunoproliferative disease, NOS|0 0 0 0 0 0 0 0 0 0 0 1 0 1 2 5 6 3 0 0
Infiltrating duct carcinoma, NOS|0 0 0 4 147 997 3134 6300 11283 17099 21520 29614 37476 42223 42345 43696 44696 41592 34582 23142
Sertoli-Leydig cl tum., p.d. w heterologous elements|0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Non-small cell carcinoma|0 0 0 0 1 2 9 32 135 349 691 1338 2033 2594 3341 4164 4276 3141 1422 923
Granulosa cell-theca cell tumor, mal.|0 0 0 0 0 0 0 0 0 1 0 0 2 1 3 0 2 0 0 0
Thymoma, type AB, malignant|0 0 0 0 0 2 0 0 2 4 6 2 6 5 12 6 4 7 0 0
Insular carcinoma|0 0 0 0 0 1 0 1 0 2 1 2 2 2 4 6 6 7 0 0
Synovial sarcoma, spindle cell|0 0 4 11 7 10 11 8 7 7 9 15 4 4 5 6 2 0 0 0
Chronic neutrophilic leukemia|0 0 0 0 0 0 0 0 0 0 0 0 0 2 1 2 2 7 0 29
Primary cutan. CD30+ T-cell lymphoprolif. disorder|0 1 1 1 3 3 1 3 3 7 12 11 15 13 24 21 20 28 18 29
Mediastinal large B-cell lymphoma|0 0 0 1 3 6 4 2 4 2 2 0 0 2 1 0 6 0 0 0
Malignant lymphoma, NOS|16 17 29 38 69 156 231 292 296 336 449 629 1079 1451 1801 2294 2821 3566 3764 3931
Pituitary adenoma, NOS|1 3 9 27 50 57 78 51 83 93 102 138 128 137 126 170 127 122 72 0
Spindle cell rhabdomyosarcoma|1 0 0 1 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0
Pseudosarcomatous carcinoma|0 0 0 0 0 1 0 2 2 5 19 24 23 52 62 67 111 86 63 0
Polycythemia vera|2 0 0 4 3 10 15 14 26 68 81 107 141 182 204 290 322 335 270 446
Angioimmunoblastic T-cell lymphoma|0 0 0 0 0 0 1 1 5 6 12 20 28 39 45 51 50 57 18 59
Lentigo maligna|1 0 1 1 10 30 64 111 246 471 786 1364 2131 2957 3548 4057 4311 3638 2854 1995
Astrocytoma, anaplastic|18 26 24 25 52 81 100 82 93 96 104 144 156 230 199 197 135 82 36 0
Lentigo maligna melanoma|0 0 0 0 6 8 18 41 86 163 267 487 776 1059 1402 1608 1891 1808 1693 1131
Carcinoma, undifferentiated type, NOS|0 0 3 11 15 22 53 71 136 267 482 849 1440 1701 1787 1608 1502 1239 954 506
Pituitary carcinoma, NOS|0 0 0 0 0 0 0 0 0 0 0 0 0 2 0 0 0 0 0 0
Hodgkin lymphoma, lymphocytic deplet., NOS|0 0 9 7 11 13 20 13 10 14 27 34 49 67 95 93 73 68 117 29
Mixed islet cell & exocrine adenocarcinoma|0 0 0 0 0 0 0 0 1 1 4 0 1 3 0 4 2 0 0 0
Malignant placental site trophoblastic tumor|0 0 0 0 2 3 1 0 0 0 0 0 0 0 0 0 0 0 0 0
Burkitt cell leukemia|6 6 3 2 1 3 1 2 2 4 2 4 6 10 13 9 14 10 0 29
Scirrhous adenocarcinoma|0 0 0 0 0 4 11 31 58 105 174 262 396 422 461 507 527 507 432 268
Carcinosarcoma, embryonal type|0 0 0 0 0 0 0 0 0 0 1 2 3 1 4 0 4 0 0 0
Olfactory neuroblastoma|0 0 2 4 5 5 6 7 11 20 17 27 34 32 13 28 24 18 9 0
Duct carcinoma, desmoplastic type|0 0 0 0 0 0 0 0 0 0 1 0 0 2 1 1 0 0 0 0
Comedocarcinoma, non-infiltrating|0 0 0 0 2 13 56 159 421 605 757 1024 1014 1223 1120 1058 813 529 261 89
Undifferentiated sarcoma|1 0 1 2 0 0 0 0 0 1 1 2 4 3 5 5 2 0 0 0
Medulloblastoma, NOS|163 156 85 43 44 37 25 18 9 8 6 4 3 1 1 0 0 3 0 0
Central osteosarcoma|0 0 0 1 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0
Comedocarcinoma, NOS|0 0 0 0 4 36 110 199 333 444 502 613 747 757 614 551 477 374 180 208
Leukemia, NOS|14 4 4 5 8 8 11 13 18 23 43 86 144 267 407 544 862 1264 1918 2055
Waldenstrom macroglobulinemia|0 0 0 0 0 0 3 6 8 25 56 95 152 218 305 418 479 479 369 119
Acute myeloid leuk. with multilineage dysplasia|0 0 0 0 2 1 1 1 4 6 13 19 38 49 65 104 125 104 72 0
Endometrioid carcinoma|0 0 0 2 18 61 182 362 682 1246 2162 3266 3671 3755 3488 3383 3558 2842 2161 1102
Malignant lymphoma, non-Hodgkin|29 42 50 58 76 103 153 191 233 327 497 827 1230 1640 1837 2238 2385 2345 2206 1548
NK/T-cell lymphoma, nasal and nasal-type|0 0 0 0 3 3 1 5 4 5 6 9 7 10 14 16 14 7 9 0
Thymoma, type B1, malignant|0 0 0 0 0 0 3 0 2 4 1 8 6 5 9 13 12 3 0 0
Angiolipoma, NOS|0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 0 0
Synovial sarcoma, epithelioid cell|0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0 0 0 0
Hypereosinophilic syndrome|0 2 0 0 0 0 0 1 3 2 3 4 3 7 9 8 8 7 0 0
Polygonal cell carcinoma|0 0 0 0 0 0 0 0 0 2 2 1 5 3 5 1 2 0 0 0
Hodgkin lymphoma, nod. scler., grade 2|0 0 5 20 37 33 39 16 21 13 8 6 4 18 10 14 16 10 0 29
Superficial spreading melanoma, in situ|1 0 2 18 56 129 167 199 242 256 291 356 389 383 348 347 280 230 198 178
Adenocarcinoma with squamous metaplasia|0 0 0 0 4 18 40 64 112 154 307 487 637 560 451 341 284 241 81 148
Superficial spreading melanoma|0 4 24 170 600 1150 1634 1782 2023 2243 2519 3124 3531 3428 3215 2909 2685 2345 1684 1459
Carcinoma, anaplastic type, NOS|0 0 0 3 4 6 17 26 59 116 188 351 594 756 768 686 744 727 612 387
Papillary adenoma, NOS|0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0
Rhabdomyosarcoma, NOS|27 18 15 16 14 7 6 6 6 11 15 19 27 39 45 45 64 68 54 0
Vipoma|0 0 0 0 0 0 0 0 0 0 1 1 1 1 2 0 0 0 0 0
Renal cell carcinoma|3 3 8 17 37 85 181 366 702 1248 2014 3332 4731 5860 5950 5999 5720 5004 3935 2680
Hodgkin lymph., lymphocyt. deplet., diffuse fibrosis|0 0 1 0 2 1 0 1 1 1 1 3 4 4 6 9 8 3 0 0
Amelanotic melanoma|0 0 0 1 10 12 11 15 19 33 36 44 68 80 95 124 121 151 126 119
Aortic body tumor, malignant|0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Adult T-cell leukemia/lymphoma (HTLV-1 pos.)|1 0 0 0 3 1 1 6 1 3 5 5 10 8 14 28 36 25 27 0
Trophoblastic tumor, epithelioid|0 0 0 0 0 0 0 2 0 0 0 0 0 0 0 0 0 0 0 0
Malignant myoepithelioma|0 0 1 0 0 0 0 1 3 1 3 0 6 7 12 5 12 10 0 0
Olfactory neuroepithelioma|0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0
Papillary adenocarcinoma, NOS|0 2 25 117 330 565 672 686 782 1076 1446 2253 3098 3628 3672 3487 3734 3357 2503 1816
Linitis plastica|0 0 0 0 2 3 9 16 22 48 68 121 184 226 265 318 336 302 243 208
Retinoblastoma, NOS|328 15 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Desmoplastic medulloblastoma|15 5 4 3 5 2 3 3 1 2 1 0 0 1 0 0 0 0 0 0
Desmoplastic small round cell tumor|0 0 4 1 3 3 4 2 0 0 0 0 0 1 0 2 0 0 0 0
Ceruminous adenocarcinoma|0 0 0 0 0 0 0 0 0 0 0 1 0 0 5 2 2 0 18 0
Endometrioid adenofibroma, malignant|0 0 0 0 0 0 0 0 1 0 1 4 5 2 3 12 10 3 0 0
Acute leukemia, NOS|72 29 22 22 25 26 27 35 35 49 73 138 249 367 597 715 1021 1340 1224 1906
Heavy chain disease, NOS|0 0 0 0 0 0 0 0 0 0 1 0 0 1 3 2 6 0 0 0
Secretory carcinoma of breast|0 0 0 1 0 1 2 0 3 2 5 7 2 4 5 6 12 3 18 29
Basal cell carcinoma, NOS|0 0 0 0 1 1 2 4 9 10 23 41 66 96 136 168 215 342 333 268
Hemangioblastoma|0 0 0 0 4 6 4 5 8 6 5 16 6 6 6 1 2 10 0 29
Acute myeloid leukemia, t(8;21)(q22;q22)|1 1 0 1 2 4 1 0 1 5 4 2 9 11 7 8 20 3 0 0
Thymoma, type B2, malignant|0 0 0 0 0 0 1 0 1 2 4 2 6 2 1 1 6 0 0 0
Synovial sarcoma, biphasic|0 2 6 11 9 8 10 5 6 6 3 6 3 6 3 1 0 3 0 0
Carcinoma with osteoclast-like giant cells|0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 2 0 0 0
Transitional meningioma|1 0 0 0 1 2 4 3 7 14 11 25 23 27 19 20 20 14 18 0
Adenocarcinoma w cartilag. & oss. metaplas.|0 0 0 0 0 0 0 0 0 1 3 0 2 2 6 1 4 3 0 29
Acute basophilic leukemia|0 0 0 0 0 0 0 0 0 0 0 0 0 0 2 1 2 0 9 0
Pleomorphic carcinoma|0 0 0 0 1 1 1 5 8 11 21 49 66 76 91 90 95 82 45 29
Basophil adenoma|0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0
Pleomorphic rhabdomyosarcoma, adult type|1 1 0 4 2 1 2 2 3 3 5 6 11 13 15 17 30 21 36 29
Acral lentiginous melanoma, malig.|0 0 0 2 7 8 11 18 25 29 40 59 87 105 135 145 172 154 144 148
Clear cell adenocarcinofibroma|0 0 0 0 0 0 0 0 0 0 1 0 0 3 1 2 0 3 9 0
Hodgkin lymphoma, lymphocyt. deplet., reticular|0 0 0 0 1 1 1 1 0 1 0 6 9 9 6 12 20 10 9 0
Somatostatinoma, malignant|0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 3 0 0
Adenocarcinoma in situ in villous adenoma|0 0 0 0 2 3 5 14 32 71 170 325 547 758 880 1069 962 1001 621 446
Carotid body tumor, malignant|0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 0 0
Basophil carcinoma|0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0
Adenocarcinoma in villous adenoma|0 0 0 0 3 9 28 60 106 243 532 1061 1832 2705 3098 3696 4313 4233 3377 1816
Superficial spreading adenocarcinoma|0 0 0 0 0 1 0 1 2 7 7 14 20 31 32 21 36 25 18 29
Papillary trans. cell carcinoma, non-invasive|0 0 0 0 1 1 8 9 22 36 69 162 238 411 547 638 651 410 288 208
Noninfiltrating intraductal papillary adenocarcinoma|0 0 0 0 0 5 22 42 100 157 186 223 332 426 511 483 479 327 216 148
Papillary trans. cell carcinoma|0 1 3 34 88 162 271 449 840 1620 3134 6369 10766 15748 18933 21369 23334 22077 19146 14117
Hepatoblastoma|143 8 3 1 0 0 0 0 0 0 0 0 0 2 3 1 4 0 9 0
Retinoblastoma, differentiated|21 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Medullomyoblastoma|0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Intraductal papillary adenocarcinoma with invasion|0 0 0 0 0 2 5 12 19 40 47 76 124 140 183 167 280 216 144 59
Multifocal superficial basal cell carcinoma|0 0 0 0 0 0 0 0 0 0 0 0 0 5 1 4 4 7 0 0
Endometrioid adenocarcinoma, secretory variant|0 0 0 0 0 1 0 1 1 2 2 2 4 4 6 2 2 0 0 0
Granular cell tumor, NOS|0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Acute myeloid leukemia, 11q23 abnormalities|0 0 0 0 0 0 0 0 0 2 0 0 1 4 5 0 10 7 0 0
Malignant histiocytosis|16 4 8 5 5 6 2 6 3 6 8 13 24 29 25 28 12 43 36 0
Clear cell sarcoma,NOS (except of kidney M-8964/3)|1 0 2 6 7 6 3 3 6 6 6 7 6 2 7 5 8 3 0 0
Thymoma, type B3, malignant|0 0 0 0 0 1 2 1 3 4 5 8 8 14 10 8 6 7 9 0
Granular cell tumor, malignant|0 0 0 0 1 1 0 0 2 3 2 3 7 2 5 2 6 3 0 29
Subcutaneous panniculitis-like T-cell lymphoma|0 0 0 1 0 0 0 1 0 0 1 3 1 4 2 2 6 0 0 0
Ac. myelomonocytic leuk. w abn. mar. eosinophils|0 0 1 0 0 3 1 1 2 2 1 7 3 5 5 6 2 3 9 0
Clear cell meningioma|0 0 0 0 1 0 0 0 1 0 0 0 1 1 2 1 2 3 0 0
Adenocarcinoma with spindle cell mataplasia|0 0 0 0 0 0 0 1 0 1 2 2 3 6 3 6 10 0 0 0
Lipoma, NOS|1 0 1 0 1 0 0 0 0 0 0 0 1 1 2 2 0 0 0 0
Signet ring cell carcinoma|0 0 1 5 29 55 97 147 235 333 501 825 1157 1585 1766 1938 2263 2262 1882 1459
Desmoplastic melanoma, malignant|0 0 0 0 1 2 11 12 18 23 39 44 75 97 120 133 223 190 198 119
Mixed type rhabdomyosarcoma|2 2 1 0 0 0 0 0 0 1 0 0 0 0 0 2 0 3 0 0
Hairy cell leukemia|0 0 0 0 3 9 31 58 91 124 146 187 207 251 235 230 243 223 144 89
Papillary meningioma|0 1 0 0 0 0 0 0 0 1 0 1 1 3 2 0 0 0 0 0
Carcinoma in situ, NOS|0 0 5 620 4214 6761 5404 3046 1993 1423 1220 1389 1634 1670 1482 1193 1169 1023 720 476
Lipid-rich carcinoma|0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 3 0 0
Paraganglioma, NOS|0 0 0 0 0 0 0 0 0 2 0 0 0 2 0 0 0 0 0 0
Extra-adrenal paraganglioma, malignant|0 0 0 0 1 1 1 2 1 1 1 2 4 1 2 0 0 0 0 0
Carcinoma, NOS|5 2 7 44 145 287 481 730 1241 2475 4511 8635 15143 22847 29795 39025 57066 74553 91435 96679
Liposarcoma, NOS|0 0 0 3 4 10 24 22 26 52 62 120 142 146 183 190 235 205 180 89
Adenocarcinoma, intestinal type|0 0 0 0 0 2 3 6 17 38 61 130 236 365 543 725 954 1026 1143 625
Odontogenic tumor, malignant|0 0 0 0 1 1 0 1 0 1 1 2 7 2 1 6 6 3 0 0
Villous adenocarcinoma|0 0 0 0 1 1 2 4 7 13 20 41 102 120 139 129 192 223 126 0
Paraganglioma, malignant|0 0 0 0 1 5 3 5 6 6 5 8 5 14 6 8 12 7 9 0
Transitional cell carcinoma, micropapillary|0 0 0 0 0 0 0 0 0 0 1 1 2 6 7 1 16 10 0 29
Pancreatoblastoma|0 1 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Retinoblastoma, undifferentiated|20 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Primitive neuroectodermal tumor|73 34 25 19 22 15 12 9 13 8 4 8 6 6 2 6 12 0 0 0
Noninfiltrating intracystic carcinoma|0 0 0 0 0 0 0 1 5 13 14 22 39 64 84 78 111 126 126 29
Infiltrating basal cell carcinoma, NOS|0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 3 9 0
Endometrioid adenocarcinoma, ciliated cell variant|0 0 0 0 0 0 0 0 0 0 0 0 2 1 2 5 2 0 0 0
Immunoproliferative small intestinal disease|0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 2 0 0 0
Intracystic carcinoma, NOS|0 0 0 0 1 2 3 5 11 14 14 24 48 68 81 102 146 129 153 148
Oligodendroblastoma|0 0 0 0 0 1 0 1 2 3 1 3 1 1 2 1 0 0 0 0
Adrenal cortical carcinoma|14 4 3 7 7 14 17 25 28 33 49 58 92 85 72 40 46 28 18 29
Hemangiopericytoma, benign|0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Hemangiopericytoma, NOS|0 0 0 0 0 0 0 0 0 1 0 1 1 1 0 0 0 0 0 0
Thymic carcinoma, NOS|0 0 0 0 0 0 0 1 4 7 3 10 10 9 15 10 4 7 0 0
Alveolar soft part sarcoma|1 2 5 7 9 11 3 3 1 1 0 2 1 0 1 1 0 0 0 0
Atypical meningioma|0 0 0 0 1 0 2 4 3 8 9 14 20 18 18 21 28 28 9 0
Adenocarcinoma with apocrine metaplasia|0 0 0 0 0 0 0 0 1 3 5 2 2 5 5 10 2 3 9 0
Cutaneous T-cell lymphoma, NOS|0 1 0 2 3 8 18 22 26 41 69 77 99 125 154 175 144 126 144 119
Acute myeloid leukemia, minimal differentiation|2 1 2 5 3 2 4 3 6 6 14 16 23 48 55 55 69 100 54 0
Hemangiopericytoma, malignant|4 2 2 2 7 4 11 11 15 11 25 21 31 24 31 41 32 28 0 29
Mucosal lentiginous melanoma|0 0 0 0 0 0 0 0 0 0 2 0 0 0 0 4 0 0 0 0
Meningeal sarcomatosis|0 0 0 0 0 0 0 0 0 1 1 0 0 1 0 0 4 0 0 0
Adenosquamous carcinoma|0 0 0 0 9 53 106 154 224 310 555 1039 1512 1768 1846 1742 1402 1088 711 297
Glycogen-rich carcinoma|0 0 0 0 0 0 0 0 0 0 0 0 0 2 0 4 0 0 0 0
Epithelioma, malignant|0 0 0 0 0 0 0 0 0 1 0 0 3 2 2 1 2 3 0 0
Adenocarcinoma in situ in tubulovillous adenoma|0 0 0 0 1 6 17 24 54 100 257 442 696 947 1112 1245 1226 1124 855 446
Liposarcoma, well differentiated|0 0 0 0 4 7 9 21 32 35 66 101 112 136 132 163 140 79 81 29
Ameloblastoma, malignant|0 0 0 2 2 2 3 3 1 3 4 3 7 12 4 9 6 10 0 0
Adenocarcinoma in tubulovillous adenoma|0 0 0 0 5 15 30 68 147 300 676 1173 1801 2690 3162 3862 4128 3714 2881 1965
Carcinoma, diffuse type|0 0 0 0 2 4 10 12 21 36 54 81 122 170 220 268 257 324 297 178
Melanoma in situ|1 2 16 66 203 370 562 718 947 1189 1452 1950 2183 2375 2529 2629 2533 2039 1693 1102
Malignant melanoma, NOS|15 17 51 228 627 1090 1372 1548 1873 2324 2799 3715 4470 4863 4955 5112 5689 5688 5196 5778
Large cell medulloblastoma|2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Bronchiolo-alveolar adenocarcinoma|0 0 0 0 1 3 15 34 92 206 488 967 1700 2289 2501 2437 1926 1142 693 446
Retinoblastoma, diffuse|0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Pulmonary blastoma|1 0 0 0 1 1 0 0 0 0 0 0 2 4 2 2 2 0 0 0
Basal cell carcinoma, fibroepithelial|0 0 0 0 0 0 0 0 0 0 0 1 2 2 1 2 0 0 0 0
Adenocarcinoma, endocervical type|0 0 0 0 1 6 10 9 7 12 6 4 6 1 2 8 4 0 0 0
Queyrat erythroplasia|0 0 0 0 1 2 2 3 1 2 6 6 14 16 9 18 18 10 9 0
Neuroblastoma, NOS|780 68 20 14 8 9 6 6 3 3 2 5 6 6 5 4 0 18 9 0
Sebaceous adenocarcinoma|0 0 0 0 0 1 1 5 5 22 21 47 61 105 134 185 259 262 315 387
Acute myeloid leukemia without maturation|3 2 4 3 9 7 6 5 10 13 13 35 33 42 74 93 81 104 27 0
Adenocarcinoma with neuroendocrine differen.|0 0 0 0 0 0 0 0 3 3 8 15 13 17 15 24 26 18 36 0
Cyst-associated renal cell carcinoma|0 0 0 0 0 1 3 6 9 17 16 17 19 28 36 18 24 25 18 0
Phyllodes tumor, malignant|0 0 2 6 9 14 18 38 50 71 72 90 80 73 53 52 73 39 72 59
Myeloid leukemia, NOS|8 3 2 4 10 8 22 11 17 26 37 61 139 212 315 391 606 684 747 685
Thecoma, malignant|0 0 0 0 1 0 0 0 0 1 1 0 4 3 5 1 2 3 0 0
Warthin tumor, malignant|0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Myxoid liposarcoma|1 1 3 9 11 37 37 51 56 52 50 74 92 105 94 97 119 111 81 59
Large cell carcinoma, NOS|0 0 0 0 6 12 39 135 359 738 1446 2734 4280 5397 5388 4932 3996 2705 1476 744
Nodular melanoma|0 3 6 27 101 148 208 227 293 351 444 625 752 900 961 1062 1329 1484 1918 1459
Pleuropulmonary blastoma|2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Alveolar adenocarcinoma|0 0 0 0 0 0 0 0 3 7 9 34 55 83 77 56 69 50 9 29
Transitional cell carcinoma in situ|0 0 0 0 1 0 2 1 3 11 24 56 92 163 231 249 213 158 126 178
Basosquamous carcinoma|0 0 0 0 0 0 0 0 2 4 5 12 11 14 28 22 52 50 72 0
Acute biphenotypic leukemia|2 1 0 1 0 0 0 0 0 0 1 2 2 4 3 5 8 0 9 0
Transitional cell carcinoma, NOS|0 0 1 6 20 36 70 131 277 632 1340 2891 5502 8003 9685 11704 14042 14234 12914 9382
Bowen disease|0 0 0 11 48 100 127 137 129 134 141 181 188 209 192 186 115 144 81 29
Nephroblastoma, NOS|542 155 24 10 9 6 3 1 4 1 3 2 4 3 3 5 0 0 0 0
Medulloepithelioma, NOS|5 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Composite Hodgkin and non-Hodgkin lymphoma|0 0 0 0 0 0 0 0 0 0 0 0 1 2 5 4 8 3 0 0
Spindle epithelial tumor with thymus-like element|0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0
Neuroma, NOS|0 0 0 0 0 0 0 1 1 1 6 5 2 1 2 4 2 3 0 0
Mast cell sarcoma|0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Acute myeloid leukemia with maturation|4 4 9 4 7 7 5 10 13 20 24 36 47 71 89 104 154 140 144 29
Metaplastic carcinoma, NOS|0 0 0 0 0 0 2 7 9 21 19 42 40 40 22 60 52 46 81 89
Renal cell carcinoma, chromophobe type|0 0 0 0 2 4 11 11 32 39 47 74 74 75 93 135 103 61 27 0
Acute myeloid leukemia|165 90 115 164 213 229 232 256 276 395 567 940 1474 2114 2764 3296 3984 3876 3755 2472
Neoplasm, benign|1 0 2 1 4 4 3 3 1 8 5 8 7 11 12 18 26 43 18 0
Epithelial-myoepithelial carcinoma|0 0 0 0 0 0 1 2 1 5 12 8 9 13 13 24 20 21 27 29
Mucinous adenocarcinoma|0 0 2 16 50 100 206 353 627 1088 1680 2847 4565 6672 8168 9757 11170 11481 9807 7178
Hodgkin lymph., nodular lymphocyte predom.|1 5 6 18 23 36 27 24 21 23 23 24 30 11 15 12 16 3 0 0
Neoplasm, uncertain whether benign or malignant|0 0 1 0 4 3 2 4 4 4 7 7 12 11 18 25 60 97 126 59
Large cell neuroendocrine carcinoma|0 0 0 0 0 0 0 3 6 11 16 52 52 82 82 114 85 79 9 0
Round cell liposarcoma|0 0 0 0 0 1 5 6 4 11 6 8 8 6 5 12 6 7 18 0
Myeloid sarcoma|4 0 1 1 1 4 1 2 3 6 9 10 19 20 37 36 24 25 36 0
Basal cell adenocarcinoma|0 0 0 0 0 0 0 0 0 3 3 8 9 14 19 12 6 7 0 29
Neoplasm, malignant|34 13 18 29 72 99 130 171 268 493 903 1786 3418 5225 8124 12334 22025 34740 51891 61653
Myxosarcoma|0 0 0 0 1 1 1 2 3 2 6 8 8 10 6 13 10 14 9 0
Balloon cell melanoma|0 0 0 0 0 1 0 0 1 1 1 2 0 1 2 2 2 10 0 0
Bronchiolo-alveolar carcinoma, non-mucinous|0 0 0 0 0 0 0 0 1 5 6 21 21 30 41 48 58 32 9 0
Intraductal micropapillary carcinoma|0 0 0 0 0 1 3 15 43 74 85 91 96 106 88 102 71 50 18 0
Ewing sarcoma|18 64 133 153 81 41 23 14 10 9 8 4 4 4 5 2 2 0 0 29
Metatypical carcinoma|0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 0 0
Steroid cell tumor, malignant|0 0 0 0 0 0 0 1 0 0 0 1 0 1 0 0 2 0 0 0
Teratoid medulloepithelioma|0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Struma ovarii, malignant|0 0 0 0 0 0 1 0 1 2 0 0 0 0 1 1 0 3 0 0
Schneiderian carcinoma|0 0 0 0 0 0 0 0 0 0 1 2 1 5 2 4 2 3 0 0
Langerhans cell histiocytosis, disseminated|29 2 1 0 2 1 0 0 0 1 1 0 0 2 3 2 0 3 0 0
Lymphoepithelial carcinoma|0 0 8 18 15 17 22 25 34 50 57 71 75 93 65 52 48 50 36 29
Oligodendroglioma, NOS|17 19 29 43 67 107 126 147 125 118 115 121 116 107 74 51 58 28 18 29
Carcinoma showing thymus-like element|0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0
Perineurioma, NOS|0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Malignant mastocytosis|0 0 0 0 2 1 2 5 5 6 8 11 19 8 11 14 20 0 0 0
Hepatoid adenocarcinoma|0 0 0 0 0 0 0 0 0 1 1 0 0 2 4 2 0 3 18 0
Chronic myelogenous leukemia, BCR/ABL positive|0 0 0 3 7 6 7 8 14 18 17 17 24 28 27 28 26 21 0 0
Perineurioma, malignant|0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Renal cell carcinoma, sarcomatoid|0 0 0 0 0 0 0 2 8 13 18 29 43 36 48 48 34 10 27 29
Trabecular adenocarcinoma|0 0 0 0 1 1 1 2 0 3 6 15 14 24 23 54 30 43 36 59
Mucin-producing adenocarcinoma|0 0 1 5 14 47 95 147 301 523 949 1755 2840 3893 4554 5090 5547 5522 4259 3008
Tumor cells, benign|0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9 0
Kaposi sarcoma|0 0 0 4 117 710 1503 1512 1079 687 374 264 202 177 250 348 501 666 765 685
Pleomorphic liposarcoma|0 0 0 0 2 0 4 3 9 12 20 26 38 52 76 71 73 86 63 29
Large cell carcinoma with rhabdoid phenotype|0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 3 0 0
Acinar cell carcinoma|0 1 12 22 21 37 34 40 97 203 580 1241 1769 2374 2156 1740 1349 997 720 238
Acute panmyelosis with myelofibrosis|0 0 0 0 0 1 0 1 0 2 2 3 10 22 14 18 16 14 0 29
Adamantinoma of long bones|0 0 1 1 2 1 2 0 2 0 1 0 1 1 0 0 0 0 0 0
Malignant melanoma, regressing|0 0 0 0 3 7 12 11 14 19 28 31 37 49 45 48 38 39 18 59
Tumor cells, malignant|1 0 0 1 3 6 7 14 24 50 92 169 345 560 684 745 945 1044 1062 1161
Bronchiolo-alveolar carcinoma, mucinous|0 0 0 0 0 0 0 1 0 8 9 12 35 44 60 56 46 32 0 59
Glomangiosarcoma|0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 0 0
Trans. cell carcinoma, spindle cell|0 0 0 0 0 0 0 0 0 2 4 6 13 12 14 37 58 54 54 0
Neuroepithelioma, NOS|8 1 2 3 2 3 1 3 1 2 2 1 0 9 3 2 4 0 0 0
Carcinoid tumor, malignant|0 0 19 48 87 150 222 272 399 617 1062 1465 1845 2230 2324 2233 2121 1761 999 506
Basaloid squamous cell carcinoma|0 0 0 0 0 0 1 3 12 24 55 65 62 83 86 74 79 57 45 0
Eccrine adenocarcinoma|0 0 0 0 1 0 0 0 1 1 1 2 4 9 11 10 12 14 9 0
Histiocytic sarcoma|0 0 0 1 0 0 0 0 0 1 4 0 4 4 0 5 6 0 0 0
Squamous cell carcinoma in situ, NOS|0 1 6 537 3978 7060 5857 3506 2395 1747 1471 1655 1951 2282 1948 1611 1493 1026 657 476
Oligodendroglioma, anaplastic|1 1 1 1 7 21 21 22 32 29 37 35 35 46 29 29 14 28 0 0
Squamous cell carcinoma, NOS|1 2 10 28 225 715 1305 1912 3381 6705 12157 22349 34704 42958 43373 40122 35479 27729 20902 15636
Sweat gland adenocarcinoma|0 0 0 0 1 5 3 3 8 12 14 23 39 35 58 49 71 68 126 148
Mast cell leukemia|0 0 0 0 1 0 0 0 0 0 0 0 1 0 1 0 2 0 0 0
Atypical chronic myeloid leuk., BCR/ABL negative|0 0 0 0 0 0 0 0 0 0 0 0 2 3 4 2 8 0 0 0
Follicular lymphoma, NOS|1 1 2 1 12 24 30 43 80 119 201 308 400 469 514 586 606 544 351 178
Collecting duct carcinoma|0 0 0 0 1 0 0 0 1 3 5 6 6 12 6 13 14 3 0 0
Chronic myeloid leukemia, NOS|26 14 27 57 105 168 221 245 252 303 415 590 841 1102 1233 1553 1993 2190 2224 1995
Mucinous adenocarcinoma, endocervical type|0 0 0 0 0 0 0 2 1 2 4 4 2 1 1 2 2 0 0 0
Chronic myelomonocytic leukemia, NOS|1 0 0 0 1 3 3 7 7 10 26 46 126 230 373 501 765 817 711 327
Glassy cell carcinoma|0 0 0 0 0 0 0 1 0 0 0 0 0 2 0 0 2 3 0 0
Mixed type liposarcoma|0 0 0 0 0 1 3 4 6 8 6 11 12 17 14 13 26 3 9 0
Acinar cell cystadenocarcinoma|0 0 0 0 0 0 0 0 0 0 0 1 0 0 1 0 0 0 0 0
Malignant tumor, small cell type|3 3 2 2 3 1 2 3 2 5 7 17 22 27 30 36 38 43 27 0
Basal cell carcinoma, nodular|0 0 0 0 0 0 0 0 0 0 1 2 1 4 6 12 18 14 45 0
Bronch.-alv. carc., mixed mucin. and non-mucinous|0 0 0 0 0 0 0 0 0 0 1 2 3 2 5 10 4 10 0 0
Squamous cell carcinoma, clear cell type|0 0 0 0 0 0 0 0 0 2 0 1 1 4 2 2 4 7 0 0
Malignant rhabdoid tumor|25 0 1 0 0 1 0 2 1 1 1 2 1 2 4 4 10 7 0 0
Enterochromaffin cell carcinoid|0 0 0 1 0 2 3 2 1 4 10 12 26 16 29 21 18 7 9 0
Basaloid carcinoma|0 0 0 0 0 0 1 3 5 6 29 41 52 76 74 70 93 108 27 89
Langerhans cell sarcoma|0 0 0 0 0 0 0 0 0 0 0 0 1 0 1 0 0 0 0 0
Mullerian mixed tumor|0 0 0 1 1 3 11 14 29 44 103 228 412 515 620 592 730 594 486 297
Pilomatrix carcinoma|0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0
Sq. cell carcinoma, keratinizing, NOS, in situ|0 0 0 2 15 32 38 25 17 18 10 22 33 33 25 28 16 28 9 0
Apocrine adenocarcinoma|0 0 0 0 0 3 5 11 21 22 42 55 87 95 110 141 148 108 135 119
Chordoma, NOS|1 1 6 8 11 8 13 19 13 24 33 42 46 76 73 63 62 61 72 29
Sq. cell carcinoma, keratinizing, NOS|0 0 0 3 25 78 183 261 420 729 1160 2038 3013 3675 3864 3545 3261 2860 2350 1935
Blue nevus, malignant|0 0 0 0 1 1 1 0 1 1 1 1 0 3 2 4 6 0 0 29
Neurilemoma, NOS|0 0 5 5 13 22 32 41 56 87 128 143 142 126 86 75 87 72 45 0
Follicular lymphoma, grade 2|0 0 0 2 11 29 53 90 152 235 335 515 654 786 863 915 901 702 396 268
Neurinomatosis|0 0 0 0 0 0 0 0 0 0 0 0 1 0 1 0 0 0 0 0
Juvenile myelomonocytic leukemia|8 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Mucinous cystadenocarcinoma, non-invasive|0 0 0 0 0 1 1 1 2 0 0 1 3 1 4 2 2 0 0 0
Neurilemmoma, malignant|3 1 10 13 31 24 22 22 22 24 28 40 56 53 63 74 56 39 27 0
Mucinous cystadenocarcinoma, NOS|0 0 1 14 45 71 88 93 111 138 209 281 329 378 367 334 324 277 225 29
Malignant tumor, giant cell type|0 0 0 0 1 1 1 1 1 3 2 5 11 18 10 16 14 18 36 89
Adenocarcinoma with mixed subtypes|0 0 0 0 1 3 1 7 17 24 55 95 141 146 174 182 198 151 144 59
Therapy-related acute myeloid leukemia, NOS|0 0 0 0 0 0 0 0 1 2 0 5 2 6 3 5 6 10 0 0
Adenoid basal cell carcinoma|0 0 0 0 0 0 0 0 0 0 0 0 1 2 4 2 6 0 0 0
Ganglioglioma, NOS|6 5 9 7 4 7 2 3 4 1 2 0 0 0 0 0 0 3 0 0
Fibrous histiocytoma, malignant|9 9 15 42 48 60 83 89 117 158 205 359 528 681 841 971 1262 1242 1305 923
Giant cell tumor of bone, malignant|0 0 2 3 9 12 4 5 4 4 1 6 1 0 7 2 4 14 0 0
Teratoma, benign|0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Clear cell sarcoma of kidney|15 2 0 0 0 0 0 0 0 0 1 1 2 1 3 0 4 0 0 0
Cloacogenic carcinoma|0 0 0 0 1 1 4 11 22 47 70 134 172 223 205 195 205 183 171 208
Ganglioglioma, anaplastic|0 0 0 2 1 1 0 0 0 1 0 1 0 0 0 1 0 0 0 0
Teratoma, NOS|0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Interdigitating dendritic cell sarcoma|0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 4 0 0 0
Sq. cell carcinoma, lg. cell, non-ker., in situ|0 0 0 2 18 45 41 25 13 9 10 12 9 14 1 6 4 3 9 59
Chondroid chordoma|0 0 0 0 0 0 0 0 1 0 0 0 0 1 1 0 0 0 0 0
Mesodermal mixed tumor|0 0 0 0 0 0 0 2 5 13 19 56 119 158 155 151 133 126 90 29
Teratoma, malignant, NOS|79 16 45 90 123 109 82 41 17 14 9 5 5 11 5 9 8 3 0 0
Sq. cell carcinoma, lg. cell, non-ker.|0 0 0 2 18 116 185 208 274 329 414 680 923 1125 1051 926 803 666 459 238
Nodular hidradenoma, malignant|0 0 0 0 1 0 0 1 3 4 4 3 11 23 19 12 30 28 63 29
Glioblastoma, NOS|20 34 45 52 92 126 167 245 407 658 1134 1855 2565 2979 3178 2968 2533 1646 1143 327
Nonencapsulated sclerosing carcinoma|0 0 0 1 3 5 8 5 6 9 16 11 9 12 9 8 12 0 0 0
Plasmacytoma, NOS|0 0 0 0 1 2 5 12 21 41 59 83 105 98 172 131 172 136 108 29
MPNST with rhabdomyoblastic differentiation|1 0 0 0 0 1 0 0 0 0 0 2 1 0 3 1 0 0 0 0
Papillary mucinous cystadenocarcinoma|0 0 0 1 5 10 15 10 10 21 32 37 39 42 71 54 36 43 18 59
Hemangioendothelioma, malignant|2 0 1 2 5 1 4 3 4 7 7 6 13 12 13 20 18 14 18 29
Comb. hepatocel. carcinoma & cholangiocarcinoma|0 0 0 0 0 0 2 0 4 10 17 14 44 49 44 52 42 18 0 29
Malignant tumor, spindle cell type|2 0 0 2 3 3 3 6 5 3 9 15 28 47 44 41 75 100 54 29
Centrol neurocytoma|0 0 0 2 1 2 2 3 1 1 0 0 0 2 0 1 0 0 0 0
Paget disease, mammary|0 0 0 0 0 0 2 8 10 24 25 50 61 80 86 99 101 140 270 178
Malignant giant cell tumor of soft parts|0 0 0 0 1 1 0 0 1 1 0 0 0 1 4 4 2 3 0 0
Goblet cell carcinoid|0 0 0 0 1 2 3 11 14 15 17 29 25 35 18 25 26 28 0 0
Pheochromocytoma|0 0 1 2 2 3 9 7 7 14 12 15 15 17 15 12 14 3 0 29
Follicular dendritic cell sarcoma|0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 1 0 0 0 0
Duct carcinoma in situ, solid type|0 0 0 0 0 2 6 22 75 112 174 214 197 216 179 232 202 144 54 119
Sq. cell carcinoma, sm. cell, non-ker.|0 0 0 0 0 4 5 5 7 11 12 23 35 45 54 45 28 7 18 0
Teratocarcinoma|3 1 10 104 249 216 140 65 34 24 10 5 9 11 4 2 0 7 0 29
Solid carcinoma, NOS|0 0 0 0 0 0 0 2 7 10 16 23 31 29 34 32 58 28 18 0
Dedifferentiated chordoma|0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Malignant eccrine spiradenoma|0 0 0 0 0 0 0 0 0 1 0 1 1 2 2 0 2 3 18 0
Giant cell glioblastoma|2 0 1 3 5 2 3 5 6 10 3 8 15 23 19 20 6 7 9 0
Capillary hemangioma|0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Multiple myeloma|0 0 0 0 5 17 54 141 320 656 1340 2535 4080 5820 6881 7982 9030 8876 7051 4080
Acute promyelocytic leuk.,t(15;17)(q22;q11-12)|11 11 20 25 38 32 54 38 43 47 55 53 81 72 98 112 69 82 54 89
Mucinous cystic tumor of borderline malignancy (C56.9)|0 0 3 16 32 46 76 63 69 87 81 80 98 107 103 74 66 72 54 0
Aggressive NK-cell leukemia|0 0 0 0 0 0 0 0 0 0 0 2 2 2 0 4 0 3 0 0
ML, large B-cell, diffuse|16 28 67 160 271 403 566 663 814 1064 1543 2202 3295 4541 5680 6845 7863 7828 7105 4199
Dedifferentiated liposarcoma|0 0 0 0 0 1 2 5 6 9 19 17 32 49 54 47 64 43 0 29
Malignant tumor, clear cell type|0 0 0 0 0 0 0 0 0 0 0 0 0 2 0 0 0 0 0 0
Paget dis. & infil. duct carcinoma|0 0 0 0 1 6 24 42 68 101 129 196 269 317 259 272 257 259 297 119
Brenner tumor, malignant|0 0 0 0 0 0 0 1 1 6 4 10 13 20 14 22 30 21 9 0
Acute myeloid leukemia, M6 type|5 0 2 1 3 5 3 6 9 10 25 48 90 118 125 153 207 208 117 59
Dermatofibrosarcoma, NOS|12 11 37 58 138 216 211 217 196 193 173 172 152 117 144 97 121 82 99 29
Malignant tenosynovial giant cell tumor|0 0 0 0 0 0 0 0 0 0 1 0 0 1 0 0 0 0 0 0
Composite carcinoid|0 0 0 0 0 0 0 2 3 4 8 11 13 26 25 18 22 7 9 29
Malignant teratoma, undiff.|0 0 0 0 1 3 0 0 0 0 0 0 0 2 0 0 0 0 0 0
Carcinoma simplex|0 0 0 0 0 0 0 0 0 1 1 4 4 12 5 12 6 21 9 0
Sq. cell carcinoma, spindle cell|0 0 0 0 1 0 0 3 7 9 28 45 66 83 130 116 115 108 90 59
Gliofibroma|0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Choroid plexus papilloma, NOS|5 0 1 1 1 1 1 0 0 1 0 2 0 1 2 0 0 0 0 0
Mixed tumor, malignant, NOS|0 0 0 0 1 5 6 4 8 14 21 32 36 56 39 55 44 61 54 59
Gliosarcoma|0 0 0 0 0 1 3 3 6 11 17 23 36 39 57 45 42 7 9 0
Plasma cell leukemia|0 0 0 0 0 0 1 1 4 4 13 14 19 26 37 37 24 54 63 29
Atypical choroid plexus papilloma|0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Mixed epithel. & spindle cell melanoma|0 0 0 2 4 7 6 10 10 26 40 52 65 105 92 99 101 86 99 29
Papillary mucinous cystadenoma, borderline malignancy (C56.9)|0 0 0 0 2 6 4 9 5 5 4 2 3 8 12 5 6 0 0 0
Plexiform neurofibroma|0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Acute myelomonocytic leukemia|15 6 11 14 22 29 30 28 43 51 61 104 180 224 306 340 477 360 441 446
Meningeal melanocytoma|0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Choroid plexus papilloma, malignant|16 1 1 0 1 1 0 0 0 0 2 2 1 0 0 0 0 0 9 0
Serous adenocarcinofibroma|0 0 0 0 0 0 0 0 0 0 0 0 2 2 1 1 0 0 0 0
Meningeal melanomatosis|0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Papillary serous cystadenocarcinoma|0 0 0 8 53 82 112 175 321 578 862 1389 2056 2199 2216 2294 1991 1513 819 536
Paget disease, extramammary|0 0 0 0 0 0 0 1 5 7 16 44 96 126 160 221 247 252 117 148
Pigmented dermatofibrosarcoma protuberans|0 0 1 0 2 0 2 1 3 3 1 2 0 1 1 1 2 0 0 0
Acute megakaryoblastic leukemia|32 0 1 0 1 1 0 3 4 4 9 10 18 26 38 29 44 25 36 0
Atypical teratoid/rhabdoid tumor|12 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Adenocarcinoid tumor|0 0 0 0 5 4 7 8 17 21 14 33 24 26 37 33 20 39 18 0
Mesenchymal chondrosarcoma|0 1 3 4 9 4 4 2 3 5 3 2 5 5 7 4 0 0 0 0
